2022 VHL International Medical Symposium
The virtual Symposium brought together researchers and medical professionals from all over the globe to discuss the latest in VHL research and treatment.
The 2022 Symposium was held in partnership with the VHL Alliance and the Toronto VHL Network. It featured a keynote address by celebrated researcher Marston Linehan, MD of the National Institutes of Health and a presentation by Nobel laureate Gregg L. Semenza, MD, PhD.
Nobel Laureate Gregg L. Semenza, MD, PhD.
Marston Linehan, MD of the National Institutes of Health
VHL Basic Science
Clinical Manifestations in VHL
Endocrine Manifestations in VHL
Canadian VHL Alliance and Cancer Research Society $120,000 research grant winners:
Sandra Turcotte, PhD
Canadian Cancer Society Research Chair, New Brunswick , Researcher in Residency, Atlantic Cancer Research Institute, Canada, Associate Professor, Department of Chemistry and Biochemistry, New Brunswick Centre for Precision Medicine, Canada
Hamed S. Najafabadi, PhD
Canada Research Chair, Systems Biology of Gene Regulation, Assistant Professor, Department of Human Genetics, McGill University, Canada
Other Canadian presenters include:
Raymond Kim, Clinician Scientist, Princess Margaret Cancer Centre, leader OICR’s Ontario Hereditary Cancer Research Network (OHCRN)
Fraser Ferens, PhD, Post-Doctoral Fellow, Oh Laboratory, University of Toronto, Toronto, Canada
Kalene van Engelen, Certified Genetic Counsellor, Canada London Health Sciences Centre, Canada
Paul Nathan, Head, Solid Tumor Section, Director, Aftercare Program, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Professor, Departments of Paediatrics and Healthy Policy, Management & Evaluation University of Toronto
Ozgur Mete, MD, Professor, University of Toronto Department of Laboratory Medicine & Pathobiology - Anatomic Pathology, Canada
Patient presenters include:
Andrew Lyle Gowan
CVHLA Board Member Jess Pearson